Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study - 21/05/19
Doi : 10.1016/j.jaad.2019.02.031
Tiago Torres, MD, PhD a, ⁎ 
, Anna Balato, MD b, Curdin Conrad, MD, PhD c, Andrea Conti, MD d, Paolo Dapavo, MD e, Paulo Ferreira, MD f, Francesca Gaiani, MD g, Luíz Leite, MD h, Piergiorgio Malagoli, MD g, Pedro Mendes-Bastos, MD f, Matteo Megna, MD b, Francesco Messina, MD i, Alessia Nidegger, MD c, Giulia Odorici, MD d, Stefano Piaserico, MD, PhD i, Francesca Prignano, MD j, Simone Ribero, MD e, Federica Ricceri, MD j, Annalisa Tonini, MD k, Joana Valério, MsC h, Andrea Chiricozzi, MD l
, Anna Balato, MD b, Curdin Conrad, MD, PhD c, Andrea Conti, MD d, Paolo Dapavo, MD e, Paulo Ferreira, MD f, Francesca Gaiani, MD g, Luíz Leite, MD h, Piergiorgio Malagoli, MD g, Pedro Mendes-Bastos, MD f, Matteo Megna, MD b, Francesco Messina, MD i, Alessia Nidegger, MD c, Giulia Odorici, MD d, Stefano Piaserico, MD, PhD i, Francesca Prignano, MD j, Simone Ribero, MD e, Federica Ricceri, MD j, Annalisa Tonini, MD k, Joana Valério, MsC h, Andrea Chiricozzi, MD l a Department of Dermatology, Centro Hospitalar Universitário do Porto, Portugal
b Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
c Department of Dermatology, Lausanne University Hospital Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland
d Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
e Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy
f CUF Descobertas Hospital, Portugal
g Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy
h Clínica Médica Belém, Portugal
i Department of Dermatology, University of Padua, Padova, Italy
j Department of Dermatology, University of Florence, Firenze, Italy
k Department of Dermatology, University of Pisa, Pisa, Italy
l Institute of Dermatology Catholic University - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
∗Correspondence to: Tiago Torres, MD, PhD, Department of Dermatology, Centro Hospitalar do Porto, Rua D. Manuel II, S/N, ex-CICAP, 4099-001 Porto, PortugalDepartment of DermatologyCentro Hospitalar do PortoRua D. Manuel II, S/N, ex-CICAPPorto4099-001Portugal
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Tuesday 21 May 2019
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| Funding sources: None. |
|
| Conflict of interest: Dr Torres has served as a scientific consultant, speaker, and clinical study investigator for AbbVie, Amgen, Boehringer Ingelheim, Biogen, Celgene, Janssen, LEO-Pharma, Eli-Lilly, MSD, Novartis, Pfizer, Samsung Bioepis, and Sanofi. Dr Conrad has served as a scientific consultant, speaker, and clinical study investigator for AbbVie, Actelion, Amgen, Celgene, Janssen, LEO Pharma, Lilly, MSD, Novartis, and Pfizer. Dr Ferreira served as scientific consultant, speaker, and clinical study investigator for AbbVie, Janssen, LEO-Pharma, Eli-Lilly, Novartis, and Pfizer. Dr Leite served as scientific consultant, speaker, and clinical study investigator for AbbVie, Janssen, Eli-Lilly, and Novartis. Dr Mendes-Bastos has served as a scientific consultant, speaker, and clinical study investigator for AbbVie, Pfizer, Janssen, LEO Pharma, Novartis, Sanofi, Teva, Bayer, and L'Oreal. Dr Piaserico has served as scientific consultant, speaker, and clinical study investigator for AbbVie, Celgene, Galderm, Janssen, LEO Pharma, Lilly, MSD, Novartis, and Pfizer. Dr Chiricozzi has served as scientific consultant, speaker, and clinical study investigator for AbbVie, Biogen, Eli Lilly and Company, Janssen, Leo Pharma, Novartis, UCB Pharma, and Sanofi Genzyme. Dr Balato, Dr Conti, Dr Dapavo, Dr Gaiani, Dr Malagoli, Dr Megna, Ms Valério, Dr Messina, Dr Nidegger, Dr Odorici, Dr Prignano, Dr Ribero, Dr Ricceri, and Dr Tonini have no conflicts of interest to disclose. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?